Paper

Development of a Multivalent Macrocyclic Peptide that Shows In Vivo Protection Against SARS-CoV-2 Infection Following Intranasal Administration

ChemRxiv · 2026 · Antonius J. P. Hopstaken, Aneta Zegar, Oliver J. Debski-Antoniak et al.